6,678 trials
Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty
Primary: Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS) — 30.2; 40.7 units on a scale
Psoriatic Nail · Psoriasis Vulgaris · Psoriasis
Primary: Mean Percent Change of mNAPSI (Modified Nail Area Psoriasis Severity Index) at Week 36 Compared to Baseline for All Nails. — 64.1 percentage of reduction in mNAPSI score…
Transfusional Hemosiderosis
Primary: Percentage of Participants With Differing Palatability Scores at Week 8 and Week 12 — 10; 0; 0; 0 percentage of participants
Hepatitis C · HIV-1-infection · Liver Diseases
Primary: Percentage of Participants With Sustained Virologic Response 12 (SVR12) — 95.0 percentage of participants
Hip Osteoarthritis
Primary: Pain at Rest After Surgery — 3.4; 3.6 score on a scale — p=.770
Neisseria Gonorrhoeae Infection
Primary: Change in Anti-N. Gonorrhoeae Outer-membrane Vesicle Specific Immunoglobulin G (IgG) Concentrations After Immunization — 61.57; 206.2 titers
Short Stature
Primary: Predicted Adult Height at Year 3 — 167.8; 169.4 cm
Influenza Immunization · Healthy Volunteers
Primary: Number of Participants Aged 6 Months to <9 Years Who Provided Serum Samples for Analysis: Groups 1 and 2 — 29; 31; 15; 30 Participants
Asthma · Allergic Rhinitis · Atopic Dermatitis
Primary: FcεRI (High Affinity Receptor) Levels at 3 Months — 20.5; 13.66 Positive cells per field
Pain
Primary: Efficacy of IV Ibuprofen in Orthropedic Trauma Patients — 74.9; 97.8 morphine equivalent dosage, mg
Pregnancy Related · Abortion Early
Primary: Number of Pharmacists Who Objected to Participate in Dispensing Mifeprex — 4 Participants
Healthy
Primary: Functional Connectivity During Nitrous Oxide — 0.1123; 0.0358; 0.1492; 0.0394 Fisher's r transformed z score — p=0.001
Secondary Progressive Multiple Sclerosis · Primary Progressive Multiple Sclerosis
Primary: Number of Participants Classified as Upper Limb Responders on the 9 Hole Peg Test (9HPT) — 4; 3; 58; 59 Participants
Bacterial Vaginosis
Primary: Number of Participants With Related Clinical Signs or Symptoms at Baseline — 63; 63 Participants — p=<0.01
Fontan
Primary: Changes in End Diastolic and End Systolic Volume as Measured by Standard and Advanced MRI Parameters — 3.3; 3.0; 3.0; 4.4 ml